How often it happens The rates vary by trial and population: 2,3 TRIUMPH-4 (obesity with knee osteoarthritis): 8.8% on 9 mg, 20.9% on 12 mg, 0.7% on placebo TRANSCEND-T2D-1 (type 2 diabetes): 4.5% on 4 mg, 2.3% on 9 mg, 4.4% on 12 mg, 0% on placebo Phase 2 trial (Jastreboff 2023): not reported The TRIUMPH-4 numbers are markedly higher than those of TRANSCEND-T2D-1
February 22, 2021
Proper technique reduces risks like vein irritation, infection, or incorrect dosing
It is unknown whether Saxenda causes thyroid C-cell tumors, including medullary thyroid carcinoma (MTC), in humans, as the human relevance of liraglutide-induced rodent thyroid C-cell tumors has not been determined
If your health insurance plan does approve coverage for your GLP-1, youll likely have a copay which typically is significantly less than the out-of-pocket cost for these medications
That phrasing changes the page from a retail buying guide into a technical procurement review focused on documentation, analytical support, and research-use-only labeling